no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Absence of Pharmacokinetic Interference of Moxifloxacin on Cyclosporine and Tacrolimus in Kidney Transplant Recipients
|
Capone, Domenico |
|
2010 |
50 |
5 |
p. 576-580 |
article |
2 |
Antihypertensive Drug Adherence Among 6408 Chinese Patients on Angiotensin-Converting Enzyme Inhibitors in Hong Kong: A Cohort Study
|
Wong, Martin C. S. |
|
2010 |
50 |
5 |
p. 598-605 |
article |
3 |
Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration
|
Karhu, David |
|
2010 |
50 |
5 |
p. 544-553 |
article |
4 |
Does Therapeutic Equivalence Follow Bioequivalence? A Randomized Trial to Assess Clinical Effects After Switching From Clozaril to Generic Clozapine (Gen-Clozapine)
|
Oluboka, Oloruntoba |
|
2010 |
50 |
5 |
p. 531-535 |
article |
5 |
Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin
|
Kirby, Lyndon C. |
|
2010 |
50 |
5 |
p. 566-575 |
article |
6 |
Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide
|
Brown, Karen S. |
|
2010 |
50 |
5 |
p. 554-565 |
article |
7 |
Long-Term Changes in Cyclosporine Pharmacokinetics After Renal Transplantation in Children: Evidence for Saturable Presystemic Metabolism and Effect of NR1I2 Polymorphism
|
Fanta, Samuel |
|
2010 |
50 |
5 |
p. 581-597 |
article |
8 |
Pharmacokinetic Characteristics of Bolus-Administered Mannitol in Patients Undergoing Elective Craniotomy
|
Kaneda, Kotaro |
|
2010 |
50 |
5 |
p. 536-543 |
article |
9 |
Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus
|
Wiczling, Paweł |
|
2010 |
50 |
5 |
p. 494-506 |
article |
10 |
Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of a Novel Sorbitol Dehydrogenase Inhibitor in Healthy Participants
|
Landau, Zohar |
|
2010 |
50 |
5 |
p. 521-530 |
article |
11 |
Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA-Naïve and ESA-Treated Chronic Kidney Disease Patients With Renal Anemia
|
Chanu, Pascal |
|
2010 |
50 |
5 |
p. 507-520 |
article |